#StartDisrupting

Join us as we dig into Start Disrupting's archive and revisit Antarctica with guests James B. McClintock, Ph.D. (The University of Alabama at Birmingham, Author and Professor of Polar and Marine Biology) and Bill J. Baker, Ph.D. (The University of South Florida, Professor of Chemistry). In this episode, Brett takes a dive below Antarctica's ice with James and Bill as they discuss drug discovery, climate change, and some of their most profound research findings. - The Baker Research Group- James B. McClintock and UAB in Antarctica- Books by James B. McClintockHost: Brett MaloneEditor and Producer: Becca Halm 

Dr. Aileen Helsel is the current Interim Director for Carilion Clinic Innovation (CCI), a catalytic agent and resource for regional innovators and creatives within the Carilion healthcare system. Since beginning her role as Interim Director in April 2022, Dr. Helsel oversees the healthcare system's efforts to develop and market disruptive Carilion inventions while also expanding the region's biotech and entrepreneurial ecosystem. Dr. Helsel has an extensive biomedical research background and after spending years at the bench she started working with Washington State University (WSU), where she successfully licensed and commercialized life science innovations. Dr. Helsel then moved across the country to begin working with CCI in 2021, where she continues to guide disruptive ideas to the marketspace. About Carilion Clinic Innovation: Carilion physicians, nurses and staff make unique discoveries through their research, and continuous improvements to the care they provide our communities. Some of these discoveries are innovations with commercial potential. First and foremost, they can benefit patients in our community. When inventions are brought to market by an Industry partner or spun out as a startup, patients across the country and globe may benefit from our employees' curiosity and commitment to innovation.Host: Brett MaloneEditor and Producer: Becca Halm 

James D. Harder is a Blockchain Ecosystem Catalyst. Currently Virginia Tech's Blockchain Initiative Director, Harder is also an External Engagement Manager for VT's Department of Computer Science. Harder has an interest in analyzing agricultural applications of blockchain, as well as other emerging technologies, such as AI and cybersecurity.Virginia Tech's Blockchain Certificate Program Wall Street Journal PodcastArchiveCoreTatiana MorozHost: Brett MaloneEditor and Producer: Becca Halm 

Amy White is Virginia Western Community College's Dean for the science, technology, engineering, and mathematics department. White began at VWCC as a biology professor in 2003, and her passion for educating led her to her role as STEM dean. White focuses on educating and mentoring those who are interested in STEM careers, as well creating equal opportunities for all students wishing to make an impact on the healthcare system. In this episode Brett and Amy discuss the importance of young minds and how STEM is so much more than science, technology, engineering, and math.  Host: Brett MaloneEditor and Producer: Becca Halm 

Dr. Zac Doerzaph is the Executive Director of the Virginia Tech Transportation Institute (VTTI), a global leader in transportation research. Working alongside a talented team, Doerzaph focuses on creating a future of ubiquitous, safe, and effective mobility by conducting innovative and impactful research today. Also, a faculty member within the Department of Biomedical Engineering and Mechanics at Virginia Tech, Doerzaph works with fellow faculty to provide experiential learning opportunities to prepare the next generation workforce. Doerzaph is known for innovative and extensive transportation research and leadership projects. His work focuses on maximizing performance at the interface of driver, vehicle, and infrastructure systems through the application of advanced technologies.Host: Brett MaloneEditor and Producer: Becca Halm 

Learn more about 3-D printing, lab on a chip, and building your business products from Skyphos Technologies Founder and CEO, Elliot McAllister. Skyphos Technologies focuses on solving the manufacturing and technology gap for lab-on-a-chip technologies by bringing ultra-small resolutions and micro-3D printing to the biotech industry.  A Virginia Tech graduate, Elliot's career has been molded by engineering and management experiences. Elliot has experience in manufacturing, R&D, robotics, drug discovery, biomedical research, and more. Edited and Produced By: Becca Halm 

Learn more about entrepreneurship and how to know you've hit traction with your startup from Active Capital Founder and CEO, Pat Matthews.Pat is the founder and general partner of Active Capital, a venture firm focused on leading seed rounds for B2B SaaS companies outside of Silicon Valley. Prior to Active Capital, Pat was an entrepreneur, operator, and angel investor.  Pat's career started in 1999 when he dropped out of Virginia Tech to start a dot-com with some of his best friends and college roommates.  After the dot-com bubble burst, Pat and his team persevered through years of economic downturn before creating Webmail.us, a $10 million dollar software company that was recognized as one of the fastest growing private companies in America by Inc. Magazine.  In 2007, Webmail.us was acquired by Rackspace where Pat worked as an executive on the senior leadership team until 2013.  Pat has personally invested in nearly 100 startups and is an active board member of the Virginia Tech Apex Center for Entrepreneurship, Venture for America in San Antonio, and several Active Capital portfolio companies.Edited and produced by: Becca Halm

Learn how Disney is utilizing technology to enhance the customer experience with new initiatives and how the Disney accelerator is creating new entertainment adventures and products. Kathy de Paolo, Vice President of Engineering at The Walt Disney Company, shares all this and entrepreneurial advice for all.Links:Kathy's LinkedIn profileWalt Disney Imagineering: https://sites.disney.com/waltdisneyimagineering/Disney:  https://www.disney.com/Disney Accelerator:  https://disneyaccelerator.com/Edited and produced by: Becca Halm 

Kenna Anderes Ph.D., RAC,  Vice President of Translational Medicine & Companion Diagnostics at Mirati Therapeutics, talks →  The art of partnering: How your small company can change the game for big companies; plus, “FIO” Figure it Out, how to follow the data, and navigate complex timelines and more. Dr. Anderes has been a scientific leader in oncology drug discovery, biomarker identification and early clinical development in the pharmaceutical and biotech industries for over 20 years. She is trained as a pharmacologist and cancer biologist and has held a number of senior executive and scientific advisory positions at pharmaceutical, biotech and in vitro diagnostic companies. As an early employee in several startup companies, Dr. Anderes acquired very broad, interdisciplinary technical and business skills, with breadth in science, clinical research, clinical operations, regulatory strategy, product/medical device development. Achievements range from lead identification of novel small molecule or biological entities to characterization of clinical development candidates for several distinct first in class molecular targeted agents to treat cancer. She has extensive experience directing and designing studies to determine relationships to drug exposure, mechanism of action, efficacy and biomarkers in the single agent and combination settings in vitro and in vivo in classical xenografts and patient derived tumor models. In parallel to drug discovery/development activities, Dr. Anderes has led equally diverse biomarker and in vitro diagnostic projects. She has evaluated numerous liquid biopsy approaches and served as an advisor on pharma sponsored clinical trials to evaluate clinical utility of CTCs and ctDNA. Delivery on the promise of personalized medicine requires strategic and tactical translational medicine expertise, Dr. Anderes formed Translational Medicine Partners, Inc. and co-founded Wild Type Advisors, LLC to provide bespoke consulting services for the life sciences, biotechnology and pharmaceutical industries.

DaSilva is the inaugural Executive Director of the Commonwealth Cyber Initiative (CCI), and the Bradley Professor of Cybersecurity at Virginia Tech.DaSilva previously held the chair of Telecommunications at Trinity College Dublin, where he served as the Director of CONNECT, a national telecommunications research center in Ireland.He has published two books and more than 300 peer-reviewed articles, and chaired the Technical Program for ICC 2020, one of the flagship conferences of the IEEE Communications Society. He was an IEEE Communications Society Distinguished Lecturer (2015-2018), a Fellow of Trinity College Dublin, and is a Fellow of the IEEE, for contributions to cognitive networking and to resource management in wireless networks.The Commonwealth Cyber Initiative (CCI) is Virginia's main access point for cybersecurity research, innovation, workforce development, and news. In this community, researchers find funding and collaboration, students discover diverse career possibilities, and new innovations come to life. Virginia is the ideal locale for CCI due to its strong base of research excellence and its diverse higher education system. These factors combined with the state's ecosystem of venture capital investment and high-growth firms, along with its density of cybersecurity talent, bring a confluence of contributors to the future success of CCI.

Brian Sullivan is anchor of CNBC's “Worldwide Exchange” (M-F, 5AM-6AM ET), which broadcasts from CNBC Global Headquarters in Englewood Cliffs, N.J.  He is also Senior National Correspondent for the network, covering some of the nation's biggest stories.Most recently, Sullivan was co-anchor of CNBC's “Power Lunch”(M-F, 1PM-3PM ET).In his 25 years of financial journalism and television experience, Sullivan has reported from five continents. He has been twice nominated for the prestigious Loeb Award; one for being recognized as among the first financial journalists to highlight the risks of the housing bubble in 2007, and the other for the 2013 CNBC documentary “America's Gun: The Rise of the AR-15.”Prior to CNBC, Sullivan served as an anchor at Fox Business News as well as a producer, reporter and anchor for Bloomberg Television.Sullivan has a B.A. in political science from Virginia Tech, where he serves on the Alumni Board, as well as a law degree from Brooklyn Law School. In his free time, he is an avid race car driver with two SCCA divisional championships.

Guests:Craig Meadows: Montgomery County AdministratorErin Burcham:  President, Verge and  Executive Director, Roanoke Blacksburg Technology CouncilMatthew Hull, Ph.D. : Research Scientist / President & Founder, Nanosafe, Inc.John Newby:  Chief Executive Officer,  Virginia Biotechnology Association Visit website |  Download flyerNew collaboration with Johnson & Johnson Innovation announced with the aim to accelerate life science sector growth in the New River and Roanoke Valleys by providing access to expert mentors, programming, and commercialization resources for startup companies  BLACKSBURG, Va. (Dec. 15, 2021) — The GO Virginia Coalition today approved a grant award to the Virginia Tech Corporate Research Center (VTCRC) to fund the expansion of laboratory space and facilities aimed at supporting the region's growing life science industry. In addition to the construction of shared lab space by the VTCRC, this project will support the creation of 125 new biotech jobs over the next five years.  “Through collaborations, we aim to fill the demand from biotechnology companies and provide full access needed to support research to commercialization aspirations,” said Brett Malone, President & CEO of the Virginia Tech Corporate Research Center. “Our sophisticated infrastructure makes us a research destination across industries and for everyone from startups to enterprise companies.”Read full press release

Becca Halm, Communications Assistant and Virginia Tech media student, interviews Brett Malone. This episode takes a deeper dive into Brett's vision for the Virginia Tech Corporate Research Center and how he is “enabling” the disrupters creating new opportunity. Listen and find out Brett's entrepreneurial thoughts and how it takes a mindset of looking at a situation differently, having the conviction to try something new and tenancy to stick with it. Bio: Brett Malone, President and CEO of the Virginia Tech Corporate Research Center, has led multiple startups as a co-founder and CEO. He has a unique background that spans software, defense, biotech, and clinical markets. Brett has a Ph.D. in Aerospace Engineering from Virginia Tech and loves mentoring startups, building space with purpose, and getting involved in all things technology related.About us: Born out of a need to translate Virginia Tech research to commercial potential, the Virginia Tech Corporate Research Center  was established in Blacksburg in 1985. Since then, it has been home to over 750 premier organizations with a common goal to disrupt industries. Today, with operations across Virginia, the research park continues to be a destination for growth and a space with purpose. 

Daniel Smith is the co-founder and director of software at Entos.  Daniel holds a Bachelor of Science in Biochemistry and a Ph.D. in computational chemistry. With a passion for science, technology, and software engineering, Daniel has completed research for Georgia Institute of Technology and the Molecular Sciences Software Institute at the Virginia Tech Corporate Research Center, before beginning his journey with Entos. With a presence in our co-working community, COgro, they are working on AI-driven chemistry for medicine. 2015 - Graduated with a Doctor of Philosophy in Computational Chemistry from Auburn University.2010 - Graduated with a Bachelor of Science in biochemistry from the College of Charleston. Worked as a postdoctoral research associate for Georgia Institute of Technology, and worked as a software scientist at The Molecular Science Software institute in Blacksburg, VA. Started at Entos in April of 2020 as co-founder and principal software engineer and is now the director of software. Has a deep passion for computational chemistry, quantum chemistry, education, science, and technology.  

In this episode, Brett Malone, Ph.D., VTCRC President/CEO, talks with Michael about TORC, the region's strengths and how it has helped the company, his vision for autonomous trucking and more. Michael Fleming official bio Torc Robotics, a pioneer in self-driving vehicles {website}Torc Robotics, headquartered in Blacksburg, Virginia, is an independent subsidiary of Daimler Truck AG, the global leader and pioneer in trucking. Founded in 2005 at the birth of the self-driving vehicle revolution, Torc has 16 years of experience in pioneering safety-critical, self-driving applications. Torc offers a complete self-driving vehicle software and integration solution and is currently focusing on commercializing self-driving trucks. “Trucking is the backbone of the U.S. economy, delivering food and products to every community in the country,” said Torc CEO Michael Fleming. “Daimler has led innovation in trucking for more than a century, from the first truck to driver assist technology. Torc is working with Daimler Truck to commercialize self-driving trucks to make our roads safer and better fulfilling our mission of saving lives.” #self-driving #entrepreneur #virginiatech #hokies #vtcrc #torc

Webster discusses his research with drug discovery and therapeutic areas, and is co-founder of Flux Therapeutics, Inc.Webster Santos bio: https://chem.vt.edu/people/faculty/teaching-and-research/wsantos.htmlProf. Webster Santos received his BS and Ph.D.  from the University of Virginia under Prof. Timothy Macdonald.  Following his doctoral studies, he moved to Harvard University as a Ruth Kirschtein NIH fellow with Prof. Gregory Verdine. At Harvard, he performed chemical biology studies targeting RNA structures as well as HIV-1 integrase. In 2006, he started as an assistant professor of chemistry at Virginia Tech and was promoted to associate then full professor in 2018. He held a chaired position as the Blackwood Junior Faculty fellow of Life Science and is currently the Agnes and Cliff Lilly faculty fellow of drug discovery. He is a co-founder of three biotech companies and received the Schug Research Award as well as an Innovator's award at Virginia Tech.  He is on the editorial advisory board of current topics in medicinal chemistry, medicinal research reviews as well as boron in the Americas.  His current research centers on developing drugs towards fatty liver disease, cancer, and multiple sclerosis, synthetic methodology of installing boron and silicon onto carbon bonds and chemical biology of targeting HIV-1 RNAs.

Words spoken by John Olver, President & CEO of Emisshield, during the #StartDisrupting podcast with Brett Malone, Ph.D. President & CEO of the Virginia Tech Corporate Research Center (VTCRC).Spotlight story: The 3,100°F ImpactHave you ever considered how many things we use in daily life here on earth that originated from NASA technology?  GPS, medical devices, audio conference bridge technology, among many, all got their start in space!In August 2021, Dr. John Olver, President and CEO of Emissield, Inc. became the 85th inductee into the Space Technology Hall of Fame for contributions to life-changing technologies emerging from global space programs. Emisshield Inc. and NASA Ames, also accepted the organizational award.  Read full story here.

Ryan King's research focuses on understanding how modest changes in electrolyte levels can have a profound impact on cardiac function, both electrically and mechanically. Through his work, he and fellow researchers are gaining a better understanding that there is no "one size fits all" electrolyte therapy in regards to cardiac function; rather, the intervention needs to be problem-specific. There are instances in which it is more important to preserve electrical function than mechanical function and vice-versa. When these instances arise it's crucial to understand what electrolyte modifications are necessary to achieve the desired results. 

Virginia Tech alumnus, Dave Lavery: LinkedInFor over a decade, David Lavery led the National Aeronautics and Space Administration (NASA) Telerobotics Technology Development Program, with responsibility for content and direction of robotics and planetary exploration research efforts. Under his leadership the program was transformed into a world-class robotics technology and systems development program impacting NASA flight programs, other government robotics projects, and the entire robotics industry. Among the major products of Lavery's research program were the Sojourner Mars rover, the first robotic rover ever successfully placed on another planet; a free-flying robotic camera used on the Space Shuttle; Dante I and II robotic volcano explorers; and the National Robotics Engineering Consortium (NREC), to transfer robotic technologies developed by NASA into the commercial robotics industry. As Program Executive for Solar System Exploration at NASA, Mr. Lavery is currently responsible for two Mars Exploration missions (2008 and 2009), the design and development oversight of the next generation of robotic Mars exploration spacecraft, the NASA Astrobiology Field Laboratory, and the Mars Advanced Technology Program. He has published more than 30 technical papers on robotic systems and technology. Lavery's current professional commitment and involvement includes the creation of the NASA Robotics Alliance Project (RAP) to inspire K-12 students in robotics, a Fellow of the National User Group Advisory Council and the KISS Institute for Practical Robotics, and National Executive Advisory Board member of FIRST Robotics.

Tony is a falconry expert, serial entrepreneur and developer of leadership and talent. Pictured is Tony and VTCRC President & CEO Brett Malone, Ph.D.Check out the latest book Tony is reading: Deep Survival: Who lives, who dies and why by Laurence Gonzales -- Tony says "It is about who panics and who stays calm in crisis situations. Very interesting and insightful book." 

About: Bruce Zoecklein & Mickey Cowden Cowden Family Farms vineyard and Cowden TechnologiesCreating Virginia wines that showcase the uniqueness of being grown and produced in the Appalachian Region.Enology and Viticulture @ Virginia TechResearch in enology is focused primarily in the area of grape and wine flavor components in addition to evaluation of vineyard management and processing alternatives. The influence of grapevine canopy management on the incidence of fruit rot metabolites and their effect on native grape aroma components is currently being investigated. Viticultural and enological practice affecting grape phenols and their polymerization and stabilization is also investigated. The evaluation of new cultivars and the wines produced from those cultivars attempts to provide practical information to enhance the growth and development of the Virginia wine industry.Emphasis AreasRelationships between vineyard management and grape aroma componentsGrape and wine flavor component isolation and characterizationGrape and wine phenols and phenol stabilityProcessing methodologies for flavor enhancementEvaluation of new cultivarsThe Analytical Services Laboratory, part of the Wine/Enology Grape Chemistry Group at Virginia Tech, was established to fulfill the analysis requirements of the regional wine industry.  The goal of this analysis program is to provide very rapid turn-around, with optimum precision and accuracy.Designed as a fee-based, full-service enology laboratory, we provide chemical, physical, microbiological and sensory analyses, including standardized reagents.  The services are available to wineries in any state, including importers and wholesalers.  Additionally, we provide analytic procedures to the individual wineries as requested.  These procedures are equipment-relevant, and do not necessarily reflect the types of analyses performed at the Enology Service Lab.For data reporting a secure website has been established.  Results of analyses are only available to the individual winemaker and to select staff members of the Enology Service Lab.  The data is posted as results are obtained.  Results of previous analysis are continuously maintained, allowing winemakers to see trends in their juice, must, or wine samples.  The website is continuously monitored for security and system back-ups are performed daily to provide the utmost in stability, security, and availability.

Follow Pallabi Saboo on LinkedIn Harmonia Holdings Group, LLC was born in 2006 at Virginia Tech's Corporate Research Center in Blacksburg, VA. We wanted to bring innovation and change to the federal IT sector. We believed (and still believe today) that with shrinking federal budgets, there are huge opportunities to bring more efficiency to government through emerging technologies. We are a fun-loving, hard-working team of close to 400 professionals who are relentless in our pursuit of high-quality, cutting-edge solutions for our customers.Thanks to RAMP,  for allowing us to record at their location in Roanoke, VA.Founded in 2017 with funding from GO Virginia, the City of Roanoke, and Virginia Western Community College, RAMP through 2020 has nurtured 24 startup businesses. In September 2020, RAMP received a major endorsement by the U.S. Economic Development Administration, which awarded a nearly $1 million grant to Valleys Innovation Council — a nonprofit organization dedicated to growing the region's innovation economy — to double RAMP's output.

Gary Warren currently serves as president and CEO of ivWatch and has championed the development of non-invasive biosensors that fulfill a huge patient safety need in healthcare. Starting ivWatch in 2010, Gary assembled a team of leading scientists, clinicians, hospitals, and investors to solve a common drug delivery problem of IV infiltration and extravasation. Gary has guided ivWatch through multiple FDA and ISO clearances for this breakthrough technology with ivWatch products now being sold on the international market. Gary has a multidisciplinary background with a 14-year career as a research scientist at NASA in aerospace and computational fluid dynamics. He then left NASA to start a successful Internet infrastructure company in the mid-1990's and served as CEO until it's sale to Symantec in 1999. At Symantec, Gary served as a senior vice president and oversaw advanced technologies, mergers and acquisitions and gateway software products. He also served as a member of the senior executive staff. After Symantec, Gary served as CEO for a venture-backed mobile platform company as smartphones were beginning to emerge as a market. After the sale of this company to Oracle, Gary worked for various venture capital companies doing financial analysis and due diligence which brought him to the work being done on IV infiltrations under a National Institutes of Health grant. Bringing over the core engineering talent and founding the company, Gary has grown ivWatch to an award-winning brand in healthcare that is changing the standard of care for IV therapy.About ivWatch, LLC  ivWatch, LLC is a biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians can leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative IV monitoring solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch, Facebook @ivWatchLLC, and LinkedIn @ivWatch-LLC, or visit www.ivWatch.com.  

Links of interest:Zero to One -  Notes on Startups, or How to Build the FutureTED talk -  The CEO of Carbon3D, Joseph DeSimone has made breakthrough contributions to the field of 3D printing. The perfect fit: Carbon + adidas collaborate to upend athletic footwear - full storyLinkedIn profile  →  Joe co-founded Carbon in 2013. Under his direction, Carbon is marrying the intricacies of molecular science with hardware and software technologies to advance the 3D printing industry beyond basic prototyping to 3D manufacturing. Throughout his career, Joe has published over 350 scientific articles and has nearly 200 issued patents in his name — with more than an additional 200 patents pending. Joe also previously co-founded several companies including Micell Technologies, Bioabsorbable Vascular Solutions, and Liquidia Technologies.As Board Chair, Joe is currently on leave from his roles as Chancellor's Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill and William R. Kenan, Jr. Distinguished Professor of Chemical Engineering at North Carolina State University and of Chemistry at the University of North Carolina. He received his BS in Chemistry from Ursinus College, and his Ph.D. in Chemistry from Virginia Tech.Joe is one of only roughly 20 individuals who have been elected to all three branches of the U.S. National Academies: the National Academy of Medicine (2014), the National Academy of Sciences (2012) and the National Academy of Engineering (2005). During his career he has received over 50 major awards and recognitions, including the 2018 National Academy of Sciences Award for Convergent Science; the 2017 $250,000 Heinz Award for Technology, the Economy and Employment; the National Medal of Technology and Innovation, awarded by President Barack Obama in 2016; the inaugural $250,000 Kabiller Prize in Nanoscience and Nanomedicine; 2015 Dickson Prize from Carnegie Mellon University; 2014 Kathryn C. Hach Award for Entrepreneurial Success from the ACS; the 2010 AAAS Mentor Award in recognition of his efforts to advance diversity in the chemistry PhD workforce; the 2007 Collaboration Success Award from the Council for Chemical Research; and the 2002 Engineering Excellence Award by DuPont.

Gary Noesner retired from the FBI in 2003 following a 30 year career as an investigator, instructor, and negotiator.   A significant focus of his career was directed toward investigating Middle East hijackings in which American citizens were victimized.   In addition, he was an FBI hostage negotiator for 23 years of his career, retiring as the Chief of the FBI's Crisis Negotiation Unit, Critical Incident Response Group, the first person to hold that position. In that capacity he was heavily involved in numerous crisis incidents covering prison riots, right-wing militia standoffs, religious zealot sieges, terrorist embassy takeovers, airplane hijackings, and over 120 overseas kidnapping cases involving American citizens.Following his retirement from the FBI he became a Senior Vice President with Control Risks, an international risk consultancy, assisting clients in managing overseas kidnap incidents.   He continues to Consult independently and speaks at law enforcement conferences and corporate gatherings around the world.He has appeared in numerous television documentaries about hostage negotiation, terrorism, and kidnapping produced by the History Channel, Nat Geo, WE, Discovery, TLC, A&E, CNN, CBS, BBC, American Heroes Network, and others.  He has been interviewed in Time, Forbes, the New Yorker, the Washington Post, the New York Times, Roll Call, the Washingtonian Magazine, the Christian Science Monitor, and other publications.  He has given speeches at major universities, done interviews on numerous radio and television programs, and was the subject of an hour long interview on NPR's Fresh Air in 2010.He has written a book about his FBI negotiation career which was published by Penguin Random House in 2010, entitled:   Stalling for Time:  My Life as an FBI Hostage Negotiator.    The book is being used in part as the basis for a six part mini-series on Waco that will air on the Paramount Network on January 24, 2018.Gary has three grown children and resides in Virginia with his wife, Carol.

Disruption and the bridge of familiarity… Jason Feifer (Editor-in-Chief of Entrepreneur Magazine, author, speaker, and host of Build for Tomorrow podcast) talks on change, advice and all things for entrepreneurs and startups.https://www.jasonfeifer.com/build-for-tomorrow/Build for Tomorrow, Not for YesterdayComing in Summer, 2022: Jason's guide to resilience, and how to adapt and use the power of change to your advantage, drawn from centuries of innovations and the greatest minds of today. https://www.jasonfeifer.com/build-for-tomorrow-book

With over ten years of experience in the field of sport and performance psychology,  Pete has worked with a wide variety of performers, including everyone from youth to D1 athletes, tactical populations, weight management clients, and athletes returning from injury.  His drive is to help people develop the capacity for sustained success, no matter what your goals are.Show links:Web: www.drkcoaching.comInstagram: @alldaydr.kPodcast: Mental Training Lab

Linda Drake, Microsoft Federal Account Executive for the National Security Group, talks about new opportunities for federal funding.Linda Drake works for Microsoft Federal as an Account Executive for the National Security Group. She is also a small business Partner at Technology Transfer Consultants (T2C), a software development company that builds innovative products, connecting research interests to technology gaps. www.t2cpartners.comLinda has been in sales, business development and account management for over 35 years.  The first half of her career was in the Commercial Business to Business market, leading teams and selling products, software, and services. In 2001 she pivoted to Government Contracting, supporting the surge in National Security requirements for DoD and the Intelligence Community.  During her career Linda worked for an entrepreneurial startup company and formed two of her own. A COVID related furlough in May 2020 prompted her and two partners to form T2C.Linda grew up in California, moving several times with her Father’s Government career before landing at Mount Vernon High School in Alexandria, VA.  She graduated from Virginia Tech with a double major in Finance and Marketing Management and has an MBA from George Mason University. Linda lives in Herndon, VA with her husband Mike Ozycz. Their oldest son Zack graduated from JMU and is employed by Deltek GovWin IQ, middle son Bill graduated from Virginia Tech and is employed by Ernst and Young and their youngest son Eddie is a Freshman at Virginia Tech (GO HOKIES!!). 

Join us as Alex Hanlon, Ph.D. (Director of the Center for Biostatistics and Health Data Science at Virginia Tech,  Professor of Statistics and works closely with researchers on the Health Science and Technology Campus in Roanoke, adjacent to Carilion Clinic and the VTC School of Medicine) and Richard Bendis (Founder, President and CEO of BioHealth Innovation, Inc. and a successful entrepreneur, angel investor, innovation and technology-based economic development leader, international speaker and consultant in the technology and healthcare industries and host of BioTalk) discuss how ‘Big data requires team science.’ Additional show notes:Who funds the N3C initiative and what goes into it?The N3C is funded by the National Center for Advancing Translational Sciences (NCATS), which is part of the NIH or the National Institutes of Health. A key component of the initiative is data harmonization, which translates the differing ways that contributing hospitals store patient data into a single, common format to facilitate analyses. Participating sites add (or they will add) data on demographics, symptoms, medications, lab test results, and outcomes over a five-year period. This will enable both short- and long-term study of the impact of COVID-19 on health outcomes.Who has access to the N3C enclave data?Data access is open to all approved users, regardless of whether they contribute data. Details for gaining access can be found on the NCATS website (see link below). Researchers can request access only after their home institution has secured a data use agreement with NCATS. For those who are not associated with an institution, they will need to complete their own DUA with NCATS.https://ncats.nih.gov/n3c/about/applying-for-accessWhat kind of tools are available in the N3C enclave to support data analyses? The platform is built to support machine learning and rigorous statistical analyses using Python and R. The idea is to provide the necessary tools to address research questions using contemporary data driven techniques along with classical methods. To tackle such projects with large scale observational data requires collaboration within a team science environment, including expertise in statistics, informatics, medicine, engineering, and so on.

Communications and transparency; it’s how you lead. Amy talks about leadership philosophy from creating a company culture to hiring the right talent, and how to invest in your own growth. Check out the podcast and understand why it’s important to find your purpose and why you need a mentor.  About Qualtrax: Qualtrax works with companies to help them meet their assurance obligations and goals through document management, automating key business processes, streamlining training management and ensuring critical industry regulations are met.Qualtrax has around 340 clients, including Walmart, the D.C. Office of the Chief Medical Examiner, Colorado Bureau of Investigation, SABIC Innovative Plastics and the Arkansas State Crime Lab.

Join us for episode 5 as Brett talks with Bo Ewald, CEO of ColdQuanta, about quantum computing information systems, plus hear some great stories on Steve Jobs and more. Learn about ColdQuanta at https://www.coldquanta.com​. About ColdQuanta: ColdQuanta leads the market in commercializing quantum atomics, the next wave of the information age. Based on the company’s Quantum Core technology, ColdQuanta manufactures components, instruments, and turnkey systems that address a broad spectrum of applications. These range from timekeeping and navigation to quantum computing, and from radiofrequency (RF) receivers to quantum communications systems.

Virginia Tech alumnus George Probst is a photographer and public speaker. His website https://www.sharkpix.com​ showcases his love for the Great White Shark and the beauty of their distinct personalities. 

Join us for episode 3 as Brett takes you on a journey with Dan to learn how their products are powering exploration and discovery, the importance of mentoring, and challenges to being an entrepreneur. Learn more about VPT at http://www.vptpower.com​.

 Join Brett as he discusses drug discovery beneath the Antarctica ice, climate change, and the research James and Bill are conducting. McClintock bio: https://www.uab.edu/cas/biology/people/faculty/james-b-mcclintockRead opinion article by McClintock - 'Pandemic isolation tips: routine, hobbies, hope, dress in drag' https://www.al.com/opinion/2021/02/pandemic-isolation-tips-routine-hobbies-hope-dress-in-drag.htmlBaker bio: https://www.usf.edu/arts-sciences/departments/chemistry/faculty/baker.aspxLearn more about the Baker Research Group http://www.bakerchemistry.com​ Other link of interest: David Kingston at Virginia Tech: https://chem.vt.edu/people/faculty/dkingston.html

President & CEO, Brett Malone, Ph.D. talks with Erik Gatenholm, CEO of Cellink, with honors that include Innovator of the Year, Founder of the Year, and has been listed in Forbes Magazine's 30 Under 30 and MIT Review’s 35 Under 35.Listen as Erik talks about how Cellink is disrupting the biotech industry.